Detection Technology is expanding with a soon-to-be-completed acquisition of French x-ray detector technology firm MultiX.
MultiX designs, manufactures, and markets x-ray detectors for high-end applications. The purchase includes MultiX's licensing agreements and patents, as well as fixed and current assets. MultiX reported net sales of 800,000 euros ($912,000 U.S.) in 2017. The company employs 17 people at its headquarters in Moirans, France.
Similarly, Detection Technology provides x-ray detectors for medical, security, and industrial applications. The Espoo, Finland-based firm posted net sales of 89 million euros ($101.4 million U.S.) last year and has more than 450 employees, with offices in Finland, China, and the U.S.
MultiX's employees will join Detection Technology. The transaction is scheduled for completion early in January 2019.
![Images show the pectoralis muscles of a healthy male individual who never smoked (age, 66 years; height, 178 cm; body mass index [BMI, calculated as weight in kilograms divided by height in meters squared], 28.4; number of cigarette pack-years, 0; forced expiratory volume in 1 second [FEV1], 97.6% predicted; FEV1: forced vital capacity [FVC] ratio, 0.71; pectoralis muscle area [PMA], 59.4 cm2; pectoralis muscle volume [PMV], 764 cm3) and a male individual with a smoking history and chronic obstructive pulmonary disorder (COPD) (age, 66 years; height, 178 cm; BMI, 27.5; number of cigarette pack-years, 43.2, FEV1, 48% predicted; FEV1:FVC, 0.56; PMA, 35 cm2; PMV, 480.8 cm3) from the Canadian Cohort Obstructive Lung Disease (i.e., CanCOLD) study. The CT image is shown in the axial plane. The PMV is automatically extracted using the developed deep learning model and overlayed onto the lungs for visual clarity.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/03/genkin.25LqljVF0y.jpg?auto=format%2Ccompress&crop=focalpoint&dpr=2&fit=crop&h=167&q=70&w=250)
